Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 Ibero- and native americans: RIBEF-CEIBA Consortium Report on population pharmacogenomics
Abstarct Pharmacogenetic variation in Latin Americans is understudied, which sets a barrier for the goal of global precision medicine. The RIBEF-CEIBA Network Consortium was established to characterize interindividual and between population variations in CYP2D6, CYP2C9, and CYP2C19 drug metabolizing...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Mary Ann Liebert
2022
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/15119 |
| Aporte de: |
| id |
I33-R139-123456789-15119 |
|---|---|
| record_format |
dspace |
| institution |
Universidad Católica Argentina |
| institution_str |
I-33 |
| repository_str |
R-139 |
| collection |
Repositorio Institucional de la Universidad Católica Argentina (UCA) |
| language |
Inglés |
| topic |
FARMACOGENETICA GENOTIPOS Cytochrome P-450 CYP2C19 Cytochrome P-450 CYP2C9 Cytochrome P-450 CYP2D6 |
| spellingShingle |
FARMACOGENETICA GENOTIPOS Cytochrome P-450 CYP2C19 Cytochrome P-450 CYP2C9 Cytochrome P-450 CYP2D6 Naranjo, María Eugenia G. Rodrigues Soares, Fernanda Peñas Lledó, Eva M. Tarazona Santos, Eduardo Fariñas, Humberto Rodeiro, Idania Terán, Enrique Grazina, Manuela Moya, Graciela E. López López, Marisol Sarmiento, Alba P. Calzadilla, Luis R. Ramírez Roa, Ronald Ortiz López, Rocío Estévez Carrizo, Francisco E. Sosa Macías, Martha Barrantes, Ramiro LLerena, Adrián Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 Ibero- and native americans: RIBEF-CEIBA Consortium Report on population pharmacogenomics |
| topic_facet |
FARMACOGENETICA GENOTIPOS Cytochrome P-450 CYP2C19 Cytochrome P-450 CYP2C9 Cytochrome P-450 CYP2D6 |
| description |
Abstarct Pharmacogenetic variation in Latin Americans is understudied, which sets a barrier for the goal of global precision medicine. The RIBEF-CEIBA Network Consortium was established to characterize interindividual and between population variations in CYP2D6, CYP2C9, and CYP2C19 drug metabolizing enzyme genotypes, which were subsequently utilized to catalog their "predicted drug metabolism phenotypes" across Native American and Ibero American populations. Importantly, we report in this study, a total of 6060 healthy individuals from Ibero-America who were classified according to their self-reported ancestry: 1395 Native Americans, 2571 Admixed Latin Americans, 96 Afro-Latin Americans, 287 white Latin Americans (from Cuba), 1537 Iberians, and 174 Argentinean Ashkenazi Jews. Moreover, Native Americans were grouped into North-, Central-, and South Amerindians (from Mexico, Costa Rica, and Peru, respectively). All subjects were studied for the most common and functional CYP2D6, CYP2C9, and CYP2C19 allelic variants, and grouped as genotype-predicted poor or ultrarapid metabolizer phenotypes (gPMs and gUMs, respectively). Native Americans showed differences from each ethnic group in at least two alleles of CYP2D6, CYP2C9, and CYP2C19. Native Americans had higher frequencies of wild-type alleles for all genes, and lower frequency of CYP2D6*41, CYP2C9*2, and CYP2C19*17 (p < 0.05). Native Americans also showed less CYP2C19 gUMs than the rest of the population sample. In addition, differences within Native Americans (mostly North vs. South) were also found. The interethnic differences described supports the need for population-specific personalized and precision medicine programs for Native Americans. To the best of our knowledge, this is the largest study carried out in Native Americans and other Ibero-American populations analyzing CYP2D6, CYP2C9, and CYP2C19 genetic polymorphisms. Population pharmacogenomics is a nascent field of global health and warrants further research and education. |
| format |
Artículo |
| author |
Naranjo, María Eugenia G. Rodrigues Soares, Fernanda Peñas Lledó, Eva M. Tarazona Santos, Eduardo Fariñas, Humberto Rodeiro, Idania Terán, Enrique Grazina, Manuela Moya, Graciela E. López López, Marisol Sarmiento, Alba P. Calzadilla, Luis R. Ramírez Roa, Ronald Ortiz López, Rocío Estévez Carrizo, Francisco E. Sosa Macías, Martha Barrantes, Ramiro LLerena, Adrián |
| author_facet |
Naranjo, María Eugenia G. Rodrigues Soares, Fernanda Peñas Lledó, Eva M. Tarazona Santos, Eduardo Fariñas, Humberto Rodeiro, Idania Terán, Enrique Grazina, Manuela Moya, Graciela E. López López, Marisol Sarmiento, Alba P. Calzadilla, Luis R. Ramírez Roa, Ronald Ortiz López, Rocío Estévez Carrizo, Francisco E. Sosa Macías, Martha Barrantes, Ramiro LLerena, Adrián |
| author_sort |
Naranjo, María Eugenia G. |
| title |
Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 Ibero- and native americans: RIBEF-CEIBA Consortium Report on population pharmacogenomics |
| title_short |
Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 Ibero- and native americans: RIBEF-CEIBA Consortium Report on population pharmacogenomics |
| title_full |
Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 Ibero- and native americans: RIBEF-CEIBA Consortium Report on population pharmacogenomics |
| title_fullStr |
Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 Ibero- and native americans: RIBEF-CEIBA Consortium Report on population pharmacogenomics |
| title_full_unstemmed |
Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 Ibero- and native americans: RIBEF-CEIBA Consortium Report on population pharmacogenomics |
| title_sort |
interethnic variability in cyp2d6, cyp2c9, and cyp2c19 genes and predicted drug metabolism phenotypes among 6060 ibero- and native americans: ribef-ceiba consortium report on population pharmacogenomics |
| publisher |
Mary Ann Liebert |
| publishDate |
2022 |
| url |
https://repositorio.uca.edu.ar/handle/123456789/15119 |
| work_keys_str_mv |
AT naranjomariaeugeniag interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT rodriguessoaresfernanda interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT penaslledoevam interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT tarazonasantoseduardo interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT farinashumberto interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT rodeiroidania interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT teranenrique interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT grazinamanuela interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT moyagracielae interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT lopezlopezmarisol interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT sarmientoalbap interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT calzadillaluisr interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT ramirezroaronald interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT ortizlopezrocio interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT estevezcarrizofranciscoe interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT sosamaciasmartha interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT barrantesramiro interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics AT llerenaadrian interethnicvariabilityincyp2d6cyp2c9andcyp2c19genesandpredicteddrugmetabolismphenotypesamong6060iberoandnativeamericansribefceibaconsortiumreportonpopulationpharmacogenomics |
| bdutipo_str |
Repositorios |
| _version_ |
1764820525516849154 |